Guias Gold

Global Initiative for Chronic Obstructive Lung Disease

ESTRATEGIA GLOBAL PARA EL DIAGNÓSTICO, TRATAMIENTO Y PREVENCIÓN DE LA ENFERMEDAD PULMONAR OBSTRUCTIVA CRÓNICA 2006
R ESUMEN

.

RESUMEN
2006

ESTRATEGIA GLOBAL PARA EL DIAGNÓSTICO, TRATAMIENTO Y PREVENCIÓN DE LA ENFERMEDAD PULMONAR OBSTRUCTIVA CRÓNICA

© 2006 Medical Communications Resources, Inc.

i

ESTRATEGIA GLOBALPARA EL DIAGNÓSTICO, TRATAMIENTO Y PREVENCIÓN DE LA ENFERMEDAD PULMONAR OBSTRUCTIVA CRÓNICA
COMITÉ EJECUTIVO GOLD
A. Sonia Buist, MD, Chair Oregon Health & Science University Portland, Oregon, USA Antonio Anzueto, MD (Representando a la American Thoracic Society) University of Texas Health Science Center San Antonio, Texas, USA Peter Calverley, MD University Hospital Aintree Liverpool, UK TeresitaS. deGuia, MD Philippine Heart Center Quezon City, Philippines Yoshinosuke Fukuchi, MD (Representando a la Asian Pacific Society for Respirology) Tokyo, Japan Christine Jenkins, MD Woolcock Institute of Medical Research North Sydney, NSW, Australia Nikolai Khaltaev, MD (Representando a la World Health Organization) Geneva, Switzerland James Kiley, PhD (Representando al National Heart, Lung, andBlood Institute, National Institutes of Health, Department of Health and Human Services) Bethesda, Maryland, USA Ali Kocabas, MD Cukurova University School of Medicine Balcali, Adana, Turkey Mará Victorina López, MD (Representando a la Latin American Thoracic Society (ALAT)) Montevideo, Uruguay Ewa Nizankowska-Mogilnicka, MD University School of Medicine Krakow, Poland Klaus F. Rabe, MD, PhD LeidenUniversity Medical Center Leiden, The Netherlands
1

Roberto Rodriguez Roisin, MD Hospital Clinic Barcelona, Spain Thys van der Molen, MD University of Groningen Groningen, The Netherlands Chris van Weel, MD (Representando a la World Organization of Family Doctors (WONCA)) University of Nijmegen Nijmegen, The Netherlands

COMITÉ CIENTIFICO GOLD
Klaus F. Rabe, MD, PhD, Chair Leiden UniversityMedical Center Leiden, The Netherlands A. G. Agusti, MD (Effective June 2006) Hospital Universitari Son Dureta Palma de Mallorca, Spain Antonio Anzueto, MD University of Texas Health Science Center San Antonio, Texas, USA Peter J. Barnes, MD National Heart and Lung Institute London, UK A. Sonia Buist, MD Oregon Health & Science University Portland, Oregon, USA Peter Calverley, MD UniversityHospital Aintree Liverpool, UK Marc Decramer, MD (Effective June 2006) University Hospital Leuven, Belgium Yoshinosuke Fukuchi, MD President Asian Pacific Society for Respirology Tokyo, Japan Paul Jones, MD (Effective June 2006) St. George’s Hospital Medical School London, UK

Financial disclosure information for members of the GOLD Committees can be found at www.goldcopd.org

ii

RobertoRodriguez Roisin, MD Hospital Clinic Barcelona, Spain Jorgen Vestbo, MD (Effective June 2006) Hvidovre University Hospital Hvidovre, Denmark Jan Zielinski, MD Institute of TB and Lung Diseases Warsaw, Poland

Carlos M. Luna, MD President, ALAT Buenos Aires, Argentina Dennis Niewoehner, MD University of Minnesota Minneapolis, Minnesota, USA Jim Reid, MD Dunedin School of Medicine University of OtagoDunedin, New Zealand Sanjay Sethi, MD VA Medical Research Buffalo, New York, USA Peter Sterk, MD Leiden University Medical Center Leiden, The Netherlands

COLABORADORES PARA CAPITULOS
Leonardo Fabbri, MD University of Modena & Reggio Emilia Modena, Italy James C. Hogg, MD St. Paul’s Hospital Vancouver, British Columbia, Canada Christine Jenkins, MD Woolcock Institute of Medical Research NorthSydney, NSW, Australia Ewa Nizankowska-Mogilnicka, MD University School of Medicine Krakow, Poland Sean Sullivan, MD University of Washington Seattle, Washington, USA Thys van der Molen, MD University of Groningen Groningen, The Netherlands Chris van Weel, MD University of Nijmegen Nijmegen, The Netherlands

LIDERES NACIONALES GOLD QUE APORTARON COMENTARIOS
Lorenzo Corbetta, MD Università di...